Hereditary Early-Onset Parkinson's Disease Caused by Mutations in PINK1
Open accessThe DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
Parkinson's disease (PD) is a neurodegenerative disorder characterized by degeneration of dopaminergic neurons in the substantia nigra. We previously mapped a locus for a rare familial form of PD to chromosome 1p36 (PARK6). Here we show that mutations in PINK1 (PTEN-induced kinase 1) are associated with PARK6. We have identified two homozygous mutations affecting the PINK1 kinase domain in three consanguineous PARK6 families: a truncating nonsense mutation and a missense mutation at a highly conserved amino acid. Cell culture studies suggest that PINK1 is mitochondrially located and may exert a protective effect on the cell that is abrogated by the mutations, resulting in increased susceptibility to cellular stress. These data provide a direct molecular link between mitochondria and the pathogenesis of PD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Evidence for mitochondrial dysfunction is provided by mutations in genes that are associated with mitochondria in familial PD [e.g., mitochondrial kinase PINK (PTEN-induced kinase 1) and Parkin (Valente et al., 2004;Poole et al., 2008)], and features of PD are caused by mitochondrial toxins (Bove ´et al., 2005).”
From Depletion of 26S Proteasomes in Mouse Brain Neurons Causes Neurodegeneration and Lewy-Like Inclusions Resembling Human Pale Bodies (2008) · cites this paper as Valente et al., 2004
In the citing paper
“Mutations in PARKIN and PINK1 are the leading causes of autosomal recessive PD [9, 10].”
From miR-27a and miR-27b regulate autophagic clearance of damaged mitochondria by targeting PTEN-induced putative kinase 1 (PINK1) (2016) · cites this paper as [10]
In the citing paper
“Multiple neurodegenerative diseases have dysfunctional mitophagic processes in neurons, as described in Parkinson’s disease (PD) (16), Huntington’s disease (17), amyotrophic lateral sclerosis (ALS) (18), and Alzheimer’s disease (AD) (19,20).”
From Alzheimer's Disease–Associated Amyloid-β Precursor Protein Prevents Aging Stress–Induced Mitophagy and Fumarate Depletion to Improve Antitumor Immunity (2025) · cites this paper as [16]
In the citing paper
“A causal association has been established between autosomal recessive forms of PD and mutations affecting the mitophagy regulators PINK1 (PTEN‐induced putative kinase 1) and PRKN/PARK2 (Parkin RBR E3 ubiquitin protein ligase) (Kitada et al, 1998; Valente et al, 2004; Narendra et al, 2008; Matsuda et al, 2010).”
From Autophagy in major human diseases (2021) · cites this paper as Valente et al, 2004
In the citing paper
“The most studied mechanism for mitophagy in mammalian cells is mediated by the cytoplasmic E3 ubiquitin ligase PARKIN [210] and the mitochondrial membrane kinase PINK1 [211].”
From AMPK, Mitochondrial Function, and Cardiovascular Disease (2020) · cites this paper as [211]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Dauer, W., & Przedborski, S. (2003) · Neuron · doi:10.1016/s0896-6273(03)00568-3 · Cited by 5,469
Chronic systemic pesticide exposure reproduces features of Parkinson's disease
Betarbet, R., Sherer, T. B., MacKenzie, G., Garcia-Osuna, M., Panov, A. V., & Greenamyre, J. T. (2000) · Nature Neuroscience · doi:10.1038/81834 · Cited by 3,683
α-Synuclein is phosphorylated in synucleinopathy lesions
Fujiwara, H., Hasegawa, M., Dohmae, N., Kawashima, A., Masliah, E., Goldberg, M. S., Shen, J., Takio, K., & Iwatsubo, T. (2002) · Nature Cell Biology · doi:10.1038/ncb748 · Cited by 2,132
Buée, L., Bussière, T., Buée-Scherrer, V., Delacourte, A., & Hof, P. R. (2000) · Brain Research Reviews · doi:10.1016/s0165-0173(00)00019-9 · Cited by 2,015
Molecular Pathways of Neurodegeneration in Parkinson's Disease
Dawson, T. M., & Dawson, V. L. (2003) · Science · doi:10.1126/science.1087753 · Cited by 1,663
Nicklas, W. J., Vyas, I., & Heikkila, R. E. (1985) · Life Sciences · doi:10.1016/0024-3205(85)90146-8 · Cited by 1,262
Understanding cell death in parkinson's disease
Jenner, P., & Olanow, C. W. (1998) · Annals of Neurology · doi:10.1002/ana.410440712 · Cited by 685
Sherer, T. B., Betarbet, R., Stout, A. K., Lund, S., Baptista, M., Panov, A. V., Cookson, M. R., & Greenamyre, J. T. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-16-07006.2002 · Cited by 581
Valente, E. M., Bentivoglio, A. R., Dixon, P. H., Ferraris, A., Ialongo, T., Frontali, M., Albanese, A., & Wood, N. W. (2001) · The American Journal of Human Genetics · doi:10.1086/319522 · Cited by 493
Self-citationChen, H.-K., Fernandez-Funez, P., Acevedo, S. F., Lam, Y. C., Kaytor, M. D., Fernandez, M. H., Aitken, A., Skoulakis, E. M. C., Orr, H. T., Botas, J., et al. (2003) · Cell · doi:10.1016/s0092-8674(03)00349-0 · Cited by 414
Research works printed but not linked: 1
- A. H. Schapiraet al., Lancet2, 1269 (1989).
Cited by
Items 301–400 of 1,043
Phosphorylated ubiquitin chain is the genuine Parkin receptor
Okatsu, K., Koyano, F., Kimura, M., Kosako, H., Saeki, Y., Tanaka, K., & Matsuda, N. (2015) · Journal of Cell Biology · doi:10.1083/jcb.201410050 · Cited by 263
DJ-1 is critical for mitochondrial function and rescues PINK1 loss of function
Hao, L.-Y., Giasson, B. I., & Bonini, N. M. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0911175107 · Cited by 263
Cytoplasmic Pink1 activity protects neurons from dopaminergic neurotoxin MPTP
Haque, M. E., Thomas, K. J., D'Souza, C., Callaghan, S., Kitada, T., Slack, R. S., Fraser, P., Cookson, M. R., Tandon, A., & Park, D. S. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705363105 · Cited by 263
Parkin negatively regulates JNK pathway in the dopaminergic neurons of Drosophila
Cha, G.-H., Kim, S., Park, J., Lee, E., Kim, M., Lee, S. B., Kim, J. M., Chung, J., & Cho, K. S. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500346102 · Cited by 263
An LRRK2 mutation as a cause for the parkinsonism in the original PARK8 family
Funayama, M., Hasegawa, K., Ohta, E., Kawashima, N., Komiyama, M., Kowa, H., Tsuji, S., & Obata, F. (2005) · Annals of Neurology · doi:10.1002/ana.20484 · Cited by 264
Recent advances into the understanding of mitochondrial fission
Elgass, K., Pakay, J., Ryan, M. T., & Palmer, C. S. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2012.05.002 · Cited by 263
Interface between tauopathies and synucleinopathies: A tale of two proteins
Galpern, W. R., & Lang, A. E. (2006) · Annals of Neurology · doi:10.1002/ana.20819 · Cited by 263
Entire Photodamaged Chloroplasts Are Transported to the Central Vacuole by Autophagy
Izumi, M., Ishida, H., Nakamura, S., & Hidema, J. (2017) · The Plant Cell · doi:10.1105/tpc.16.00637 · Cited by 263
Characterization of PINK1 processing, stability, and subcellular localization
Lin, W., & Kang, U. J. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05398.x · Cited by 262
Ubiquitination and the Regulation of Membrane Proteins
Foot, N., Henshall, T., & Kumar, S. (2017) · Physiological Reviews · doi:10.1152/physrev.00012.2016 · Cited by 262
Absence of nigral degeneration in aged parkin/DJ‐1/PINK1 triple knockout mice
Kitada, T., Tong, Y., Gautier, C. A., & Shen, J. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06350.x · Cited by 261
Biomarker of Neuroinflammation in Parkinson’s Disease
Liu, T.-W., Chen, C.-M., & Chang, K.-H. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084148 · Cited by 259
Mitochondrial Dysfunction in Alzheimer’s Disease and the Rationale for Bioenergetics Based Therapies
Onyango, I. G., Dennis, J., & Khan, S. M. (2016) · Aging and Disease · doi:10.14336/ad.2015.1007 · Cited by 260
The Parkinson-associated protein PINK1 interacts with Beclin1 and promotes autophagy
Michiorri, S., Gelmetti, V, Giarda, E., Lombardi, F., Romano, F., Marongiu, R., Nerini-Molteni, S., Sale, P., Vago, R., Arena, G., et al. (2010) · Cell Death & Differentiation · doi:10.1038/cdd.2009.200 · Cited by 260
Self-citationGenetic perspective on the role of the autophagy-lysosome pathway in Parkinson disease
Gan-Or, Z., Dion, P. A., & Rouleau, G. A. (2015) · Autophagy · doi:10.1080/15548627.2015.1067364 · Cited by 260
Quality Control of Mitochondrial Proteostasis
Baker, M. J., Tatsuta, T., & Langer, T. (2011) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a007559 · Cited by 260
PINK1-linked parkinsonism is associated with Lewy body pathology
Samaranch, L., Lorenzo-Betancor, O., Arbelo, J. M., Ferrer, I., Lorenzo, E., Irigoyen, J., Pastor, M. A., Marrero, C., Isla, C., Herrera-Henriquez, J., et al. (2010) · Brain · doi:10.1093/brain/awq051 · Cited by 258
Wei, H., Liu, L., & Chen, Q. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2015.03.013 · Cited by 257
Mai, S., Klinkenberg, M., Auburger, G., Bereiter-Hahn, J., & Jendrach, M. (2010) · Journal of Cell Science · doi:10.1242/jcs.059246 · Cited by 256
“…of the PINK1 protein or mutations such as the G309D point mutation are linked with the autosomal recessive Parkinson’s disease (PD) variant PARK6 (Valente et al., 2004), resulting in mitochondrial deficiencies characterized by complex I dysfunction, reduced membrane potential and increased…”
BackgroundSelf-citationSeirafi, M., Kozlov, G., & Gehring, K. (2015) · The FEBS Journal · doi:10.1111/febs.13249 · Cited by 256
Paisán‐Ruiz, C., Guevara, R., Federoff, M., Hanagasi, H., Sina, F., Elahi, E., Schneider, S. A., Schwingenschuh, P., Bajaj, N., Emre, M., et al. (2010) · Movement Disorders · doi:10.1002/mds.23221 · Cited by 256
Ved, R., Saha, S., Westlund, B., Perier, C., Burnam, L., Sluder, A., Hoener, M., Rodrigues, C. M. P., Alfonso, A., Steer, C., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m505910200 · Cited by 255
Mitochondrial dysfunction in the limelight of Parkinson's disease pathogenesis
Banerjee, R., Starkov, A. A., Beal, M. F., & Thomas, B. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2008.11.007 · Cited by 253
Zhou, L.-Y., Zhai, M., Huang, Y., Xu, S., An, T., Wang, Y.-H., Zhang, R.-C., Liu, C.-Y., Dong, Y.-H., Wang, M., et al. (2019) · Cell Death & Differentiation · doi:10.1038/s41418-018-0206-4 · Cited by 254
Decision between mitophagy and apoptosis by Parkin via VDAC1 ubiquitination
Ham, S. J., Lee, D., Yoo, H., Jun, K., Shin, H., & Chung, J. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1909814117 · Cited by 252
Genetic clues to the pathogenesis of Parkinson's disease
Vila, M., & Przedborski, S. (2004) · Nature Medicine · doi:10.1038/nm1068 · Cited by 255
Role of DJ-1 in the mechanism of pathogenesis of Parkinson's disease
Dolgacheva, L. P., Berezhnov, A. V., Fedotova, E. I., Zinchenko, V. P., & Abramov, A. Y. (2019) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-019-09798-4 · Cited by 254
Rekatsina, M., Paladini, A., Piroli, A., Zis, P., Pergolizzi, J. V., & Varrassi, G. (2020) · Advances in Therapy · doi:10.1007/s12325-019-01148-5 · Cited by 252
Syntaxin-17 delivers PINK1/parkin-dependent mitochondrial vesicles to the endolysosomal system
McLelland, G.-L., Lee, S. A., McBride, H. M., & Fon, E. A. (2016) · Journal of Cell Biology · doi:10.1083/jcb.201603105 · Cited by 250
Programming axonal mitochondrial maintenance and bioenergetics in neurodegeneration and regeneration
Cheng, X.-T., Huang, N., & Sheng, Z.-H. (2022) · Neuron · doi:10.1016/j.neuron.2022.03.015 · Cited by 251
The foxa2 gene controls the birth and spontaneous degeneration of dopamine neurons in old age
Kittappa, R., Chang, W. W., Awatramani, R. B., & McKay, R. D. G. (2007) · PLoS Biology · doi:10.1371/journal.pbio.0050325 · Cited by 251
“These genes include a-synuclein [37], parkin [38], DJ-1 [39], PINK1 [40], and most recently, LRRK2 [41,42].”
Transcriptional responses to oxidative stress: Pathological and toxicological implications
Ma, Q. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.11.004 · Cited by 251
Role of Cdk5-Mediated Phosphorylation of Prx2 in MPTP Toxicity and Parkinson's Disease
Qu, D., Rashidian, J., Mount, M. P., Aleyasin, H., Parsanejad, M., Lira, A., Haque, E., Zhang, Y., Callaghan, S., Daigle, M., et al. (2007) · Neuron · doi:10.1016/j.neuron.2007.05.033 · Cited by 251
Molecular pathogenesis of Parkinson's disease
Gandhi, S., & Wood, N. W. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi308 · Cited by 251
Self-citationEtiology of Parkinson’s disease
Schapira, A. H. V. (2006) · Neurology · doi:10.1212/wnl.66.10_suppl_4.s10 · Cited by 250
Neurobiology and treatment of Parkinson's disease
Schapira, A. H. V. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2008.10.005 · Cited by 247
A Dimeric PINK1-containing Complex on Depolarized Mitochondria Stimulates Parkin Recruitment
Okatsu, K., Uno, M., Koyano, F., Go, E., Kimura, M., Oka, T., Tanaka, K., & Matsuda, N. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.509653 · Cited by 249
Kazlauskaite, A., Martínez‐Torres, R. J., Wilkie, S., Kumar, A., Peltier, J., Gonzalez, A., Johnson, C., Zhang, J., Hope, A. G., Peggie, M., et al. (2015) · EMBO reports · doi:10.15252/embr.201540352 · Cited by 249
“Mutations in genes encoding the protein kinase PTEN-induced kinase 1 (PINK1) and the ubiquitin E3 ligase, Parkin, are causal for early-onset Parkinson’s disease (PD) [1,2].”
Self-citationGeneration of CRISPR/Cas9-mediated gene-targeted pigs via somatic cell nuclear transfer
Zhou, X., Xin, J., Fan, N., Zou, Q., Huang, J., Ouyang, Z., Zhao, Y., Zhao, B., Liu, Z., Lai, S., et al. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1744-7 · Cited by 249
Molecular Pathogenesis of Parkinson Disease
Eriksen, J. L., Wszolek, Z., & Petrucelli, L. (2005) · Archives of Neurology · doi:10.1001/archneur.62.3.353 · Cited by 248
Drosophila Models of Neurodegenerative Diseases
Lu, B., & Vogel, H. (2009) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathol.3.121806.151529 · Cited by 248
Ko, H. S., von Coelln, R., Sriram, S. R., Kim, S. W., Chung, K. K. K., Pletnikova, O., Troncoso, J., Johnson, B., Saffary, R., Goh, E. L., et al. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.2172-05.2005 · Cited by 247
Structure, function, and regulation of mitofusin‐2 in health and disease
Chandhok, G., Lazarou, M., & Neumann, B. (2018) · Biological Reviews · doi:10.1111/brv.12378 · Cited by 247
PINK1 drives Parkin self-association and HECT-like E3 activity upstream of mitochondrial binding
Lazarou, M., Narendra, D. P., Jin, S. M., Tekle, E., Banerjee, S., & Youle, R. J. (2013) · Journal of Cell Biology · doi:10.1083/jcb.201210111 · Cited by 236
Programmed Cell Death in Parkinson's Disease
Venderova, K., & Park, D. S. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a009365 · Cited by 247
PINK1 is recruited to mitochondria with parkin and associates with LC3 in mitophagy
Kawajiri, S., Saiki, S., Sato, S., Sato, F., Hatano, T., Eguchi, H., & Hattori, N. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.02.016 · Cited by 245
Novel PINK1 mutations in early‐onset parkinsonism
Hatano, Y., Li, Y., Sato, K., Asakawa, S., Yamamura, Y., Tomiyama, H., Yoshino, H., Asahina, M., Kobayashi, S., Hassin‐Baer, S., et al. (2004) · Annals of Neurology · doi:10.1002/ana.20251 · Cited by 245
Whole genome expression profiling of the medial and lateral substantia nigra in Parkinson’s disease
Moran, L. B., Duke, D. C., Deprez, M., Dexter, D. T., Pearce, R. K. B., & Graeber, M. B. (2006) · neurogenetics · doi:10.1007/s10048-005-0020-2 · Cited by 242
Association of DJ-1 and parkin mediated by pathogenic DJ-1 mutations and oxidative stress
Moore, D. J., Zhang, L., Troncoso, J., Lee, M. K., Hattori, N., Mizuno, Y., Dawson, T. M., & Dawson, V. L. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi007 · Cited by 245
The Extending Network of FOXO Transcriptional Target Genes
van der Vos, K. E., & Coffer, P. J. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3419 · Cited by 243
LRRK2 Modulates Vulnerability to Mitochondrial Dysfunction in Caenorhabditis elegans
Saha, S., Guillily, M. D., Ferree, A., Lanceta, J., Chan, D., Ghosh, J., Hsu, C. H., Segal, L., Raghavan, K., Matsumoto, K., et al. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.2281-09.2009 · Cited by 243
Jinn, S., Drolet, R. E., Cramer, P. E., Wong, A. H.-K., Toolan, D. M., Gretzula, C. A., Voleti, B., Vassileva, G., Disa, J., Tadin-Strapps, M., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1616332114 · Cited by 243
Mitochondrial dysfunction in neurodegenerative diseases and cancer
de Moura, M. B., dos Santos, L. S., & Van Houten, B. (2010) · Environmental and Molecular Mutagenesis · doi:10.1002/em.20575 · Cited by 243
Radical medicine: treating ageing to cure disease
Finkel, T. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1763 · Cited by 234
Uittenbogaard, M., & Chiaramello, A. (2014) · Current Pharmaceutical Design · doi:10.2174/1381612820666140305224906 · Cited by 239
Early‐onset familial parkinsonism due to POLG mutations
Davidzon, G., Greene, P., Mancuso, M., Klos, K. J., Ahlskog, J. E., Hirano, M., & DiMauro, S. (2006) · Annals of Neurology · doi:10.1002/ana.20831 · Cited by 239
Heat Shock Prevents Alpha-synuclein-induced Apoptosis in a Yeast Model of Parkinson's Disease
Flower, T. R., Chesnokova, L. S., Froelich, C. A., Dixon, C., & Witt, S. N. (2005) · Journal of Molecular Biology · doi:10.1016/j.jmb.2005.06.060 · Cited by 238
The ubiquitin signal and autophagy: an orchestrated dance leading to mitochondrial degradation
Yamano, K., Matsuda, N., & Tanaka, K. (2016) · EMBO reports · doi:10.15252/embr.201541486 · Cited by 237
Truban, D., Hou, X., Caulfield, T. R., Fiesel, F. C., & Springer, W. (2016) · Journal of Parkinson’s Disease · doi:10.3233/jpd-160989 · Cited by 237
“Among others, the identification of the two genes associated with PD, PINK1 (PARK6) [22] and Parkin (PARK2) [23], became milestones in PD research.”
BackgroundPRKN-regulated mitophagy and cellular senescence during COPD pathogenesis
Araya, J., Tsubouchi, K., Sato, N., Ito, S., Minagawa, S., Hara, H., Hosaka, Y., Ichikawa, A., Saito, N., Kadota, T., et al. (2019) · Autophagy · doi:10.1080/15548627.2018.1532259 · Cited by 237
Liang, H., He, S., Yang, J., Jia, X., Wang, P., Chen, X., Zhang, Z., Zou, X., McNutt, M. A., Shen, W. H., et al. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.03.023 · Cited by 236
Puschmann, A. (2013) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2013.01.020 · Cited by 238
Bioactivity of Olive Oil Phenols in Neuroprotection
Angeloni, C., Malaguti, M., Barbalace, M., & Hrelia, S. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18112230 · Cited by 236
The Genetics of Parkinson’s Disease and Implications for Clinical Practice
Day, J. O., & Mullin, S. (2021) · Genes · doi:10.3390/genes12071006 · Cited by 234
Tamguney, T., & Stokoe, D. (2007) · Journal of Cell Science · doi:10.1242/jcs.015230 · Cited by 234
The Role of Sex and Sex Hormones in Neurodegenerative Diseases
Vegeto, E., Villa, A., Della Torre, S., Crippa, V., Rusmini, P., Cristofani, R., Galbiati, M., Maggi, A., & Poletti, A. (2020) · Endocrine Reviews · doi:10.1210/endrev/bnz005 · Cited by 232
PINK1-PRKN mediated mitophagy: differences between in vitro and in vivo models
Han, R., Liu, Y., Li, S., Li, X.-J., & Yang, W. (2023) · Autophagy · doi:10.1080/15548627.2022.2139080 · Cited by 229
Efficient genetic encoding of phosphoserine and its nonhydrolyzable analog
Rogerson, D. T., Sachdeva, A., Wang, K., Haq, T., Kazlauskaite, A., Hancock, S. M., Huguenin-Dezot, N., Muqit, M. M. K., Fry, A. M., Bayliss, R., et al. (2015) · Nature Chemical Biology · doi:10.1038/nchembio.1823 · Cited by 233
Self-citationiPS cell technologies: significance and applications to CNS regeneration and disease
Okano, H., & Yamanaka, S. (2014) · Molecular Brain · doi:10.1186/1756-6606-7-22 · Cited by 233
Parkinson's Disease Genetics and Pathophysiology
Vázquez-Vélez, G. E., & Zoghbi, H. Y. (2021) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-100720-034518 · Cited by 232
The human genome and drug discovery after a decade. Roads (still) not taken
Isserlin, R., Bader, G. D., Edwards, A. M., Frye, S. V., Willson, T. M., & Yu, F. H. (2011) · arXiv (Cornell University) · doi:10.48550/arxiv.1102.0448 · Cited by 232
Expanding the ubiquitin code through post‐translational modification
Herhaus, L., & Dikic, I. (2015) · EMBO reports · doi:10.15252/embr.201540891 · Cited by 232
Mitochondria in the signaling pathways that control longevity and health span
Akbari, M., Kirkwood, T. B. L., & Bohr, V. A. (2019) · Ageing Research Reviews · doi:10.1016/j.arr.2019.100940 · Cited by 230
Mitochondrial Medicine for Aging and Neurodegenerative Diseases
Reddy, P. H. (2008) · NeuroMolecular Medicine · doi:10.1007/s12017-008-8044-z · Cited by 230
“As with the other genes that cause autosomal recessive parkinsonism, PINK1 has been suggested to have neuroprotective properties against a variety of cellular stresses, a function that is lost by the mutation G309D, which has been identified in certain PD families (Valente et al. 2004).”
BackgroundMeulener, M. C., Xu, K., Thomson, L., Ischiropoulos, H., & Bonini, N. M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601891103 · Cited by 230
Evolving and Expanding the Roles of Mitophagy as a Homeostatic and Pathogenic Process
Gustafsson, Å. B., & Dorn, G. W. (2019) · Physiological Reviews · doi:10.1152/physrev.00005.2018 · Cited by 228
Mitochondria as a Therapeutic Target for Aging and Neurodegenerative Diseases
H. Reddy, P., & P. Reddy, T. (2011) · Current Alzheimer Research · doi:10.2174/156720511795745401 · Cited by 227
Progress in unraveling the genetic etiology of Parkinson disease in a genomic era
Verstraeten, A., Theuns, J., & Van Broeckhoven, C. (2015) · Trends in Genetics · doi:10.1016/j.tig.2015.01.004 · Cited by 226
Kinase signaling cascades in the mitochondrion: a matter of life or death
Horbinski, C., & Chu, C. T. (2005) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.09.030 · Cited by 225
Structure, function and toxicity of alpha‐synuclein: the Bermuda triangle in synucleinopathies
Villar‐Piqué, A., Lopes da Fonseca, T., & Outeiro, T. F. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13249 · Cited by 218
Van Laar, V. S., Arnold, B., Cassady, S. J., Chu, C. T., Burton, E. A., & Berman, S. B. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddq531 · Cited by 225
Hattingen, E., Magerkurth, J., Pilatus, U., Mozer, A., Seifried, C., Steinmetz, H., Zanella, F., & Hilker, R. (2009) · Brain · doi:10.1093/brain/awp293 · Cited by 222
Hollville, E., Carroll, R. G., Cullen, S. P., & Martin, S. J. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.06.001 · Cited by 222
Mitophagy and Parkinson's disease: The PINK1–parkin link
Deas, E., Wood, N. W., & Plun-Favreau, H. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2010.08.007 · Cited by 222
Self-citationMitochondrial modulation: reversible phosphorylation takes center stage?
Pagliarini, D. J., & Dixon, J. E. (2006) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2005.11.005 · Cited by 223
Inflammation is genetically implicated in Parkinson’s disease
Dzamko, N., Geczy, C. L., & Halliday, G. M. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2014.10.028 · Cited by 222
Pathogenic mutations in Parkinson disease
Tan, E.-K., & Skipper, L. M. (2007) · Human Mutation · doi:10.1002/humu.20507 · Cited by 223
Mitophagy in Parkinson’s Disease: From Pathogenesis to Treatment
Liu, J., Liu, W., Li, R., & Yang, H. (2019) · Cells · doi:10.3390/cells8070712 · Cited by 222
Organellophagy: Eliminating cellular building blocks via selective autophagy
Okamoto, K. (2014) · Journal of Cell Biology · doi:10.1083/jcb.201402054 · Cited by 220
Protein aggregation and degradation mechanisms in neurodegenerative diseases.
Takalo, M., Salminen, A., Soininen, H. S., Hiltunen, M. O., & Haapasalo, A. (2013) · Europe PMC (PubMed Central) · Cited by 283
Gehrke, S., Wu, Z., Klinkenberg, M., Sun, Y., Auburger, G., Guo, S., & Lu, B. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2014.12.007 · Cited by 219
Self-citationModeling Parkinson’s Disease in C. elegans
Cooper, J. F., & Van Raamsdonk, J. M. (2018) · Journal of Parkinson’s Disease · doi:10.3233/jpd-171258 · Cited by 218
Berg, D., Youdim, M. B. H., & Riederer, P. (2004) · Cell and Tissue Research · doi:10.1007/s00441-004-0976-5 · Cited by 220
Rakovic, A., Shurkewitsch, K., Seibler, P., Grünewald, A., Zanon, A., Hagenah, J., Krainc, D., & Klein, C. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.391680 · Cited by 218
The genetic landscape of Parkinson's disease
Lunati, A., Lesage, S., & Brice, A. (2018) · Revue Neurologique · doi:10.1016/j.neurol.2018.08.004 · Cited by 215
Narrative Review: Protein Degradation and Human Diseases: The Ubiquitin Connection
Reinstein, E., & Ciechanover, A. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-145-9-200611070-00010 · Cited by 216
Parkinson’s disease as a result of aging
Rodriguez, M., Rodriguez‐Sabate, C., Morales, I., Sanchez, A., & Sabate, M. (2015) · Aging Cell · doi:10.1111/acel.12312 · Cited by 214
Mechanisms and roles of mitophagy in neurodegenerative diseases
Wang, Y., Liu, N., & Lu, B. (2019) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13140 · Cited by 213
Association of PINK1 and DJ-1 confers digenic inheritance of early-onset Parkinson's disease
Tang, B., Xiong, H., Sun, P., Zhang, Y., Wang, D., Hu, Z., Zhu, Z., Ma, H., Pan, Q., Xia, J.-H., et al. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl104 · Cited by 212
Drosophila DJ-1 mutants show oxidative stress-sensitive locomotive dysfunction
Park, J., Kim, S. Y., Cha, G.-H., Lee, S. B., Kim, S., & Chung, J. (2005) · Gene · doi:10.1016/j.gene.2005.06.040 · Cited by 213
Metadata
- Authors
- Valente, E. M., Abou-Sleiman, P. M., Caputo, V., Muqit, M. M. K., Harvey, K., Gispert, S., Ali, Z., Del Turco, D., Bentivoglio, A. R., Healy, D. G., Albanese, A., Nussbaum, R., González-Maldonado, R., Deller, T., Salvi, S., Cortelli, P., Gilks, W. P., Latchman, D. S., Harvey, R. J., Dallapiccola, B., Auburger, G., & Wood, N. W.
- Affiliations
- National Hospital for Neurology and Neurosurgery (GB)
- CSS IRCCS, Mendel Institute, viale Regina Margherita 261, 00198 Rome, Italy.
- Goethe University Frankfurt (DE)
- Università Cattolica del Sacro Cuore (IT)
- National Institutes of Health (US)
- University of Modena and Reggio Emilia (IT)
- Corresponding author
- Valente, Enza Maria
- ORCID
- Venue
- Science
- Published
- 2004-05-21
- Volume
- 304
- Issue
- 5674
- Pages
- 1158-1160
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2136388422
- Cited by
- 3,481
- References
- 19
- Citations by year
- 2026: 101 · 2025: 140 · 2024: 168 · 2023: 133 · 2022: 158 · 2021: 187 · 2020: 182 · 2019: 158 · 2018: 167 · 2017: 189 · 2016: 147 · 2015: 151 · 2014: 158 · 2013: 177 · 2012: 163
- FWCI
- 109.31
- Type
- journal article
- Language
- en
- Open access
- green
- figshare.com
- Licence
- cc-by
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
- Funders
- Parkinson's UK (G-4029)
- Brain Research Trust
- Deutsche Forschungsgemeinschaft
- Ministero della Salute
- Medical Research Council
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
- Health Sciences › Medicine › Clinical Neurology › Deep Brain Stimulation and Movement Disorders
- Keywords
- Parkinson's disease, PINK1, mitochondrial dysfunction, dopaminergic neuron loss, consanguineous family, nonsense mutation, missense mutations, mitochondrial localization
- MeSH terms
- PTEN-Induced Putative Kinase, Amino Acid Sequence, Animals, Exons, Humans, Leupeptins, Membrane Potentials, Mitochondria, Molecular Sequence Data, Mutation, Neurons, Parkinson Disease, Protein Kinases, Transfection, Apoptosis, Protein Structure, Tertiary, Oxidative Stress, Codon, Nonsense, COS Cells, Mutation, Missense, Cell Line, Tumor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.